Colorcon invests in significant expansion of its South Asia production facility

Colorcon invests in significant expansion of its South Asia production facility

Harleysville, PA, May 1, 2014. Colorcon, Inc. , a leading global excipient company announces the completion of a major expansion of  capacity at its South Asia production facility in Verna, Goa, India.  Colorcon provides industry leading film coatings, modified release technologies, functional excipients and tablet design services to the pharmaceutical industry.  Its products meet the highest standards for quality, efficiency and safety.  The investment in incremental manufacturing capacity is evidence of Colorcon's ongoing commitment to the Indian pharmaceutical and nutraceutical industries.

The Goa plant is one of six Colorcon manufacturing plants dedicated to film coatings.  These plants are strategically located close to key customer centers in India, China, Europe, North America and Japan.  Speaking at the facility's grand opening event, Subodh Priolkar, Regional Managing Director for South Asia said the investment would enable Colorcon to continue to meet the needs of its customers through security of supply and short lead times.  "Having been established in the region for over 30 years, Colorcon is proud to be the supplier of choice for film coatings and excipients to the pharmaceutical industry in India and South Asia. We are excited about the plant expansion and are well positioned to continue supporting the growth of our customers in the region. Our customers value our commitment to the region and our ability to support them throughout the entire product lifecycle, from the product design stage to production with services like tablet design, technical and regulatory support. 

Martti Hedman, CEO of Colorcon, Inc. who also attended the opening event said "India is one of the fastest growing pharmaceutical markets due to improving standard of living, easier access to western medicine and increase of lifestyle diseases. India is also the most important production cluster of generic medicines for global markets. Colorcon is investing heavily in India to support its customers during both development and manufacture. Speed to market, cost to produce and consistently high product quality are our customers' strategic objectives. Colorcon continues to work relentlessly to help our customers to meet these objectives better than any other supplier"

The Goa site operates under schedule M of the Indian FDA and IPEC guidelines, with Colorcon accredited to the latest ISO 9001 standard. 

Company information

About Colorcon

Colorcon is a world leader in the development, supply and technical support of formulatedfilm coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our extensive application data and value-added services to support all phases of solid oral dose design and development. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice.  That reputation is based on the superior product quality, unparalleled technical support, and extensive regulatory assistance we provide.

 Colorcon and Dow Pharma & Food Solutions work together through the Controlled Release Alliance to bring joint resource to accelerate pharmaceutical product development efforts and reach markets throughout the world. Colorcon has exclusive, global sales and distribution rights for Dow Pharma & Food Solutions' products used in controlled release pharmaceutical applications.

 For more information, visit  



CONTACT:                                                                                                        MEDIA CONTACT:               

Deborah J. Taylor                                                                                     Richard Hayhurst

Global Marketing Communications Manager                       Richard Hayhurst Associates, Ltd.

Phone: +44-1322-627234                                                                  Phone: +44 7711-821527

[email protected]                                                                                        [email protected]